1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Allergan to purchase Neotract

Discussion in 'Neotract' started by Anonymous, Apr 25, 2014 at 12:52 PM.

  1. anonymous

    anonymous Guest

    Urologists only care about reimbursement. PERIOD.
     
  2. anonymous

    anonymous Guest

    So much for your knowledge of "the space". 25m market? You're a joke.
    Sold for 1.1B. This therapy will be the standard of care in BPH